| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.497 |
Evidence |
|
| APC |
IPI00215877 |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
0.497 |
Evidence |
|
| RPS6KB1 |
IPI00216132 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
0.497 |
Evidence |
|
| MYF6 |
MYF6: Myogenic factor 6 |
TTN |
IPI00179357 |
0.497 |
Evidence |
|
| MYF6 |
MYF6: Myogenic factor 6 |
TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
0.497 |
Evidence |
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
0.497 |
Evidence |
|
| POLR2E |
POLR2E: DNA-directed RNA polymerases I, II, and III subunit RPABC1 |
CPSF1 |
CPSF1, CPSF160: Cleavage and polyadenylation specificity factor subunit 1 |
0.497 |
Evidence |
|
| POLA |
POLA1, POLA: DNA polymerase alpha catalytic subunit |
POLD1 |
POLD1, POLD: DNA polymerase delta catalytic subunit |
0.497 |
Evidence |
O
|
| TTR |
TTR, PALB: Transthyretin precursor |
LBP |
LBP: Lipopolysaccharide-binding protein precursor |
0.497 |
Evidence |
|
| GSR |
GSR, GLUR, GRD1: Glutathione reductase, mitochondrial precursor |
USP14 |
USP14, TGT: Ubiquitin carboxyl-terminal hydrolase 14 |
0.497 |
Evidence |
|
| OXSR1 |
OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 |
TAF5 |
TAF5, TAF2D: Transcription initiation factor TFIID subunit 5 |
0.497 |
Evidence |
|
| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
NPM1 |
NPM1, NPM: Nucleophosmin |
0.497 |
Evidence |
|
| CS |
CS: Citrate synthase, mitochondrial precursor |
GOT2 |
GOT2: Aspartate aminotransferase, mitochondrial precursor |
0.497 |
Evidence |
|
| EIF5B |
EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B |
PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
0.497 |
Evidence |
|
| PQBP1 |
PQBP1, NPW38, JM26: Polyglutamine-binding protein 1 |
CPSF1 |
CPSF1, CPSF160: Cleavage and polyadenylation specificity factor subunit 1 |
0.497 |
Evidence |
|
| PQBP1 |
PQBP1, NPW38, JM26: Polyglutamine-binding protein 1 |
POLR2G |
POLR2G: DNA-directed RNA polymerase II subunit RPB7 |
0.497 |
Evidence |
|
| PQBP1 |
PQBP1, NPW38, JM26: Polyglutamine-binding protein 1 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
0.497 |
Evidence |
|
| POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
CPSF1 |
CPSF1, CPSF160: Cleavage and polyadenylation specificity factor subunit 1 |
0.497 |
Evidence |
|
| AURKA |
AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 |
USP14 |
USP14, TGT: Ubiquitin carboxyl-terminal hydrolase 14 |
0.497 |
Evidence |
|
| TCERG1 |
TCERG1, CA150, TAF2S: Transcription elongation regulator 1 |
POLR2G |
POLR2G: DNA-directed RNA polymerase II subunit RPB7 |
0.497 |
Evidence |
|
| DVL2 |
DVL2: Segment polarity protein dishevelled homolog DVL-2 |
CDK4 |
CDK4: Cell division protein kinase 4 |
0.497 |
Evidence |
|
| BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
EZH2 |
EZH2: Enhancer of zeste homolog 2 |
0.497 |
Evidence |
|
| MAP1LC3B |
MAP1LC3B, MAP1ALC3: Microtubule-associated proteins 1A/1B light chain 3B precurs |
ATG3 |
ATG3, APG3, APG3L: Autophagy-related protein 3 |
0.497 |
Evidence |
|
| SPEN |
SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein |
BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
0.497 |
Evidence |
|
| SETDB1 |
SETDB1, KIAA0067: Histone-lysine N-methyltransferase SETDB1 |
BRMS1 |
BRMS1: Breast cancer metastasis-suppressor 1 |
0.497 |
Evidence |
|